We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+16.16%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$130M
AUM Growth
+$34M
(+35%)
Cap. Flow
+$20M
Cap. Flow
% of AUM
15.37%
Top 10 Holdings %
Top 10 Hldgs %
63.42%
Holding
63
New
18
Increased
8
Reduced
9
Closed
10
Top Buys
| 1 |
Sanofi
SNY
|
+$11.5M |
| 2 |
Biogen
BIIB
|
+$7.82M |
| 3 |
Puma Biotechnology
PBYI
|
+$5.84M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$4.59M |
| 5 |
GSK
GSK
|
+$3.28M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$5.98M |
| 2 |
Edwards Lifesciences
EW
|
+$5.15M |
| 3 |
Zimmer Biomet
ZBH
|
+$4.82M |
| 4 |
Aclaris Therapeutics
ACRS
|
+$3.76M |
| 5 |
NTUS
Natus Medical Inc
NTUS
|
+$3.16M |
Sector Composition
| 1 | Healthcare | 88.21% |
| 2 | Industrials | 4.3% |
| 3 | Financials | 3.64% |
| 4 | Technology | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $16.3M | 12.58% |
58,452
+2,508
| +4% | +$640K |
|
|
2
Sanofi
SNY
$104B
| $12.2M | 9.42% |
+270,422
| New | +$11.5M |
|
|
3
GSK
GSK
$104B
| $11M | 8.49% |
209,210
+64,561
| +45% | +$3.28M |
|
4
Philips
PHG
$26.3B
| $7.84M | 6.04% |
329,787
+46,842
| +17% | +$1.05M |
|
|
5
Biogen
BIIB
$28.8B
| $7.56M | 5.82% |
+27,650
| New | +$7.82M |
|
6
Rigel Pharmaceuticals
RIGL
$757M
| $6.25M | 4.81% |
188,818
+62,479
| +49% | +$1.59M |
|
|
7
Puma Biotechnology
PBYI
$422M
| $5.95M | 4.58% |
+160,064
| New | +$5.84M |
|
|
TRHC
8
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.58M | 4.3% |
414,045
+25,991
| +7% | +$373K |
|
9
Eli Lilly
LLY
$1.02T
| $4.86M | 3.74% |
57,786
-9,214
| -14% | -$738K |
|
|
AET
10
DELISTED
Aetna Inc
AET
| $4.73M | 3.64% |
37,100
+17,100
| +86% | +$2.15M |
|
11
Cardinal Health
CAH
$53.3B
| $4.73M | 3.64% |
57,950
-10,935
| -16% | -$861K |
|
|
12
Thermo Fisher Scientific
TMO
$200B
| $4.61M | 3.55% |
+30,000
| New | +$4.59M |
|
|
AAAP
13
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $4.33M | 3.33% |
108,523
-44,809
| -29% | -$1.55M |
|
|
DMK
14
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $3.75M | 2.89% |
12,612
-2,403
| -16% | -$606K |
|
15
UnitedHealth
UNH
$385B
| $3.47M | 2.67% |
21,151
+4,964
| +31% | +$813K |
|
16
Medtronic
MDT
$105B
| $2.42M | 1.86% |
+30,000
| New | +$2.34M |
|
17
Smith & Nephew
SNN
$13.1B
| $2.39M | 1.84% |
+77,244
| New | +$2.36M |
|
18
Boston Scientific
BSX
$64.6B
| $2.24M | 1.72% |
90,000
-23,500
| -21% | -$571K |
|
19
Teva Pharmaceuticals
TEVA
$37B
| $2.23M | 1.72% |
+69,500
| New | +$2.37M |
|
|
CCXI
20
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.14M | 1.65% |
294,150
-31,100
| -10% | -$224K |
|
21
Vertex Pharmaceuticals
VRTX
$121B
| $2.13M | 1.64% |
+19,475
| New | +$1.71M |
|
22
Globus Medical
GMED
$10.6B
| $1.78M | 1.37% |
+60,000
| New | +$1.64M |
|
23
Rocket Pharmaceuticals
RCKT
$401M
| $1.45M | 1.12% |
+181,725
| New | +$1.22M |
|
24
Coherus Oncology
CHRS
$222M
| $1.35M | 1.04% |
+63,800
| New | +$1.57M |
|
|
VIRX
25
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.28M | 0.98% |
+8,912
| New | +$1.27M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA